β2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 478-486

  Nie, Mei ^a   Knox, Alan J ^a   Pang, Linhua ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXAMETHASONE; EOTAXIN; FLUTICASONE; GLUCOCORTICOID; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; LYSINE; SALBUTAMOL; SALMETEROL; TUMOR NECROSIS FACTOR ALPHA; ANDROSTANE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA CHEMOKINE; DNA; DRUG DERIVATIVE; HISTONE; MESSENGER RNA; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ACETYLATION; ARTICLE; BINDING AFFINITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; WESTERN BLOTTING; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; RESPIRATORY SYSTEM; SMOOTH MUSCLE;

ACETYLATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; BASE SEQUENCE; CELL LINE; CHEMOKINES, CC; DEXAMETHASONE; DNA; GLUCOCORTICOIDS; HISTONES; HUMANS; MUSCLE, SMOOTH; MUTATION; NF-KAPPA B; RESPIRATORY SYSTEM; RNA, MESSENGER; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21244495174     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.478     Document Type: Article

References (43)

1. Rankin, S. M., D. M. Conroy, and T. J. Williams. 2000. Eotaxin and eosinophil recruitment: implications for human disease. Mol. Med. Today 6: 20-27.
2. Pauwels, R. A., C. G. Lofdahl, D. S. Postma, A. E. Tattersfield, P. O'Byrne, P. J. Barnes, and A. Ullman. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337: 1405-1411.
3. Shrewsbury, S., S. Pyke, and M. Britton. 2000. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Br. Med. J. 320: 1368-1373.
4. 2- agonist and corticosteroids. FASEB J. 15: 261-269.
5. 2-agonists and corticosteroids of TNFα induced IL-8 release from cultured human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 23: 79-85.
6. 2-Adrenoceptor agonists inhibit release of eosinophil- activating cytokines from human airway smooth muscle cells. Br. J. Pharmacol. 132: 729-741.
7. Tattersfield, A. E., A. J. Knox, J. R. Britton, and I. P. Hall. 2002. Asthma. Lancet 360: 1313-1322.
8. Ponath, P. D., S. Qin, D. J. Ringer, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97: 604-612.
9. Matsukura, S., C. Stellato, J. R. Plitt, C. Bickel, K. Miura, S. N. Georas, V. Casolaro, and R. P. Schleimer. 1999. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells. J. Immunol. 163: 6876-6883.
10. Jedrzkiewicz, S., H. Nakamura, E. S. Silverman, A. D. Luster, N. Mansharamani, K. H. In, G. Tamura, and C. M. Lilly. 2000. IL-1β induces eotaxin gene transcription in A549 airway epithelial cells through NF-κB. Am. J. Physiol. 279: L1058-L1065.
11. Hoeck, J., and M. Woisetschläger. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNFα-induced fibroblasts. J. Immunol. 166: 4507-4515.
12. Beato, M. 1996. Chromatin structure and the regulation of gene expression: remodelling at the MMTV promoter. J. Mol. Med. 74: 711-724.
13. Wu, J., and M. Grunstein. 2000. 25 years after the nucleosome model: chromatin modifications. Trends Biochem. Sci. 25: 619-623.
14. Torchia, J., C. Glass, and M. G. Rosenfeld. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10: 373-383.
15. Goodrich, J. A., G. Cutler, and R. Tjian. 1996. Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell 84: 825-830.
16. Kadonaga, J. T. 1998. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92: 307-313.
17. Rundlett, S. E., A. A. Carmen, N. Suka, B. M. Turner, and M. Grunstein. 1998. Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 392: 831-835.
18. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352.
19. Ito, K., P. J. Barnes, and I. M. Adcock. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell Biol. 20: 6891-6903.
20. Pang, L., and A. J. Knox. 1997. Effect of interleukin-1β, tumour necrosis factor-α and interferon-γ on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121: 579-587.
21. Stylianou, E., M. Nie, A. Ueda, and L. Zhao. 1999. c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells. Kidney Int. 56: 873-882.
22. Mikita, T., D. Campbell, P. Wu, K. Williamson, and U. Schindler. 1996. Requirements for interleukin-4-induced gene expression and functional characterization of STAT6. Mol. Cell. Biol. 16: 5811-5820.
23. Pang, L., M. Nie, L. Corbett, and A. J. Knox. 2003. Cyclooxygenase-2 expression by non-steroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J. Immunol. 170: 1043-1051.
24. Nie, M., L. Pang, H. Inoue, and A. J. Knox. 2003. Transcriptional regulation of cyclooxygenase-2 by bradykinin and IL-1β in human airway smooth muscle cells: involvement of different promoter elements, transcription factors and histone H4 acetylation. Mol. Cell Biol 23: 9233-9244.
25. Atasoy, U., S. L. Curry, I. Lopez de Silanes, A. B. Shyu, V. Casolaro, M. Gorospe, and C. Stellato. 2003. Regulation of eotaxin gene expression by TNF-α and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J. Immunol. 171: 4369-4378.
26. Pallisgaard, N., N. Calusen, H. Schroder, and P. Hokland. 1999. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12,21) TEL-AMLI fusion transcript. Gene Chromosome Cancer 26: 355-365.
27. Farmer, P., and J. Pugin. 2000. β-Adrenergic agonists exert their "antiinflammatory" effects in monocytic cells through the IκB/NF-κB pathway. Am. J. Physiol. 279: L675-L682.
28. Ohtsuka, T., A. Kubota, T. Hirano, K. Watanabe, H. Yoshida, M. Tsurufuji, Y. Iizuka, K. Konishi, and S. Tsurufuji. 1996. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-κB activation. J. Biol Chem. 271: 1651-1659.
29. Ollivier, V., G. C. N. Parry, R. R. Cobb, D. De Prost, and N. Mackman. 1996. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271: 20828-20835.
30. Parry, G. C., and N. Mackman. 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159: 5450-5456.
31. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferase. Cell 87: 953-959.
32. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5: 392-401.
33. Martinez-Balbas, M. A., A. J. Bannister, M. Martin, P. Haus-Seuffert, M. Meisterernst, and T. Kouzarides. 1998. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17: 2886-2893.
34. Mulholland, N. M., S. K. Snyder, S. S. Kolla, and C. L. Smith. 2003. Chromatin-dependent regulation of the MMTV promoter by cAMP signalling is mediated through distinct pathways. Exp. Cell Res. 287: 361-373.
35. Ito, K., E. Jazrawi, B. Cosio, P. J. Barnes, and I. M. Adcock. 2001. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 276: 30208-30215.
36. Smith, C. L., and G. L. Hager. 1997. Transcriptional regulation of mammalian genes in vivo. J. Biol. Chem. 272: 27493-27496.
37. Chen, L. F., and W. C. Greene. 2003. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 81: 549-557.
38. Chen, L. F., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653-1657.
39. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21: 6539-6548.
40. Adam, E., V. Quivy, F. Bex, A. Chariot, Y. Collette, C. Vanhulle, S. Schoonbroodt, V. Coffin, T. L.-A. Nguyên, G. Gloire, et al. 2003. Potentiation of tumor necrosis factor-induced NF-κB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBα. Mol. Cell. Biol. 23: 6200-6209.
41. 2-adrenergic agonists in primary human lung fibroblasts and vascular smooth muscle cells. J. Biol. Chem. 274: 1005-1010.
42. 2-agonists on bronchial airway smooth muscle cells through synchronised cellular signaling. Lancet 360: 1293-1299.
43. Ito, K., G. Caramori, S. Lim, T. Oates, K. F. Chung, P. J. Barnes, and I. M. Adcock. 2002. Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. 166: 392-396.